Estimate Recalculated Nov 4, 2024 02:33AM EST
Domain Partners VIII, L.P. has an estimated net worth of $210 Million. This is based on reported shares across multiple companies, which include OTONOMY, INC., Dicerna Pharmaceuticals Inc, Bionano Genomics, Inc., GLAUKOS Corp, VERACYTE, INC., Atara Biotherapeutics, Inc., Syndax Pharmaceuticals Inc, Alliqua BioMedical, Inc., aTYR PHARMA INC, Durata Therapeutics, Inc., ACHILLION PHARMACEUTICALS INC, and Ocera Therapeutics, Inc..
Domain Partners VIII, L.P.'s CIK is 0001465144
2014 was Domain Partners VIII, L.P.'s most active year for acquiring shares with 6 total transactions. Domain Partners VIII, L.P.'s most active month to acquire stocks was the month of July. 2014 was Domain Partners VIII, L.P.'s most active year for disposing of shares, totalling 12 transactions. Domain Partners VIII, L.P.'s most active month to dispose stocks was the month of July. 2012 saw Domain Partners VIII, L.P. paying a total of $7,006,824.00 for 3,006,132 shares, this is the most they've acquired in one year. In 2014 Domain Partners VIII, L.P. cashed out on 8,627,034 shares for a total of $595,584.00, their largest year based on trade value.
Attention insiders:Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!